TIDE (Tumor Immune Dysfunction and Exclusion) analysis, which estimates the cytotoxic T lymphocyte level (CTL score) in tumor samples, also demonstrated a positive correlation between CXCL14 expression and CTL score in TNBC (Figure 6B). The gene discussed is CXCL14; the disease is neoplasm.